Wu A, Wu A, Chen C, Moreno R, Wu J, Wong P
J Funct Biomater. 2025; 16(2).
PMID: 39997597
PMC: 11856975.
DOI: 10.3390/jfb16020063.
Stolarczyk E, Strzempek W, Muszynska M, Kubiszewski M, Witkowska A, Trzcinska K
Int J Mol Sci. 2025; 26(3).
PMID: 39940856
PMC: 11817374.
DOI: 10.3390/ijms26031088.
Wehbe N, Mesmar J, El Kurdi R, Al-Sawalmih A, Badran A, Patra D
Sci Rep. 2025; 15(1):4286.
PMID: 39905108
PMC: 11794841.
DOI: 10.1038/s41598-024-81875-0.
Albulaihed Y, Mishra P, Saeed M, Alabdallah N, Ginawi T, Ansari I
Front Pharmacol. 2024; 15:1438237.
PMID: 39534088
PMC: 11555439.
DOI: 10.3389/fphar.2024.1438237.
Verma J, Kumar C, Sharma M, Saxena S
3 Biotech. 2024; 14(11):263.
PMID: 39387004
PMC: 11458872.
DOI: 10.1007/s13205-024-04110-7.
Global research and current trends on nanotherapy in lung cancer research: a bibliometric analysis of 20 years.
Singh P, Semwal P, Gargi B, Painuli S, Aschner M, Alsharif K
Discov Oncol. 2024; 15(1):539.
PMID: 39384612
PMC: 11465009.
DOI: 10.1007/s12672-024-01332-2.
Novel TiO-Supported Gold Nanoflowers for Efficient Photocatalytic NO Abatement.
Slapnicar S, Zerjav G, Zavasnik J, Roskaric M, Finsgar M, Pintar A
Molecules. 2024; 29(14).
PMID: 39064911
PMC: 11279453.
DOI: 10.3390/molecules29143333.
Metal-based nanoparticle in cancer treatment: lessons learned and challenges.
Hheidari A, Mohammadi J, Ghodousi M, Mahmoodi M, Ebrahimi S, Pishbin E
Front Bioeng Biotechnol. 2024; 12:1436297.
PMID: 39055339
PMC: 11269265.
DOI: 10.3389/fbioe.2024.1436297.
Core-Tunable Dendritic Polymer: A Folate-Guided Theranostic Nanoplatform for Drug Delivery Applications.
Koti N, Timalsena T, Kajal K, Worsley C, Worsley A, Worsley P
ACS Omega. 2024; 9(28):30544-30558.
PMID: 39035936
PMC: 11256300.
DOI: 10.1021/acsomega.4c02258.
Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.
Petrovic S, Bita B, Barbinta-Patrascu M
Int J Mol Sci. 2024; 25(11).
PMID: 38892030
PMC: 11172476.
DOI: 10.3390/ijms25115842.
Stability-Enhanced Cisplatin Gold Nanoparticles As Therapeutic Anticancer Agents.
Cho T, Reipa V, Gorham J, Pettibone J, Tona A, Johnston-Peck A
ACS Appl Nano Mater. 2024; 7(1).
PMID: 38846932
PMC: 11155487.
DOI: 10.1021/acsanm.3c04935.
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery.
Large D, Soucy J, Hebert J, Auguste D
Adv Ther (Weinh). 2024; 2(1).
PMID: 38699509
PMC: 11064891.
DOI: 10.1002/adtp.201800091.
Supramolecular Chemotherapy: Complexation by Carboxylated Pillar[6]arene for Decreasing Cytotoxicity of Nitrogen Mustard to Normal Cells and Enhancing Its Antitumor Efficiency against Breast Cancer.
Zhang J, Zhang X, Yuan B, Zhang H, Wang X, Wang H
ACS Omega. 2024; 9(10):11829-11835.
PMID: 38497008
PMC: 10938388.
DOI: 10.1021/acsomega.3c09353.
Recent nanotheranostic approaches in cancer research.
Gupta D, Roy P, Sharma R, Kasana R, Rathore P, Gupta T
Clin Exp Med. 2024; 24(1):8.
PMID: 38240834
PMC: 10799106.
DOI: 10.1007/s10238-023-01262-3.
Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review.
Silva D, Melo A, Uchoa A, Pereira G, Alves A, Vasconcellos M
Int J Mol Sci. 2023; 24(23).
PMID: 38069043
PMC: 10706257.
DOI: 10.3390/ijms242316719.
Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma.
Hernandez-Esparza M, Fratoddi I, Cerra S, Juarez-Moreno K, Huirache-Acuna R
Nanoscale Adv. 2023; 5(24):7077-7085.
PMID: 38059041
PMC: 10696946.
DOI: 10.1039/d3na00605k.
Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.
Bagheri M, Zandieh M, Daryab M, Samaei S, Gholami S, Rahmanian P
Transl Oncol. 2023; 39:101838.
PMID: 38016356
PMC: 10698329.
DOI: 10.1016/j.tranon.2023.101838.
Harnessing Nuclear Energy to Gold Nanoparticles for the Concurrent Chemoradiotherapy of Glioblastoma.
Li J, Kuo Y, Liao W, Yang Y, Chen S, Chien Y
Nanomaterials (Basel). 2023; 13(21).
PMID: 37947667
PMC: 10650840.
DOI: 10.3390/nano13212821.
Surface enhanced Raman scattering investigation of tecovirimat on silver, gold and platinum loaded silica nanocomposites: Theoretical analysis (DFT) and molecular modeling.
G F N, V V, M G, S M, M P
Heliyon. 2023; 9(10):e21122.
PMID: 37916120
PMC: 10616345.
DOI: 10.1016/j.heliyon.2023.e21122.
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook.
Obidiro O, Battogtokh G, Akala E
Pharmaceutics. 2023; 15(7).
PMID: 37513983
PMC: 10384267.
DOI: 10.3390/pharmaceutics15071796.